Delving into the Latest Updates on Shenyang Xinrui Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Small molecule drug	1

主要目的比较空腹和餐后给药条件下，沈阳欣瑞制药有限公司提供的艾拉莫德片（25mg）与海南先声药业有限公司持证的艾拉莫德片（25mg，商品名：艾得辛®）在健康成年人群中吸收程度和速度的差异，评价其生物等效性。次要目的评价空腹和餐后给药条件下，沈阳欣瑞制药有限公司提供的艾拉莫德片（25mg）与海南先声药业有限公司持证的艾拉莫德片（25mg，商品名：艾得辛®）在健康成年人群中的安全性。

[Translation]

Primary Objective: To compare the absorption rate and extent of absorption of Ailamod tablets (25 mg) supplied by Shenyang Xinrui Pharmaceutical Co., Ltd. and Ailamod tablets (25 mg, trade name: Aidesin®) certified by Hainan Xiansheng Pharmaceutical Co., Ltd. in a healthy adult population under fasting and postprandial administration conditions, and to evaluate their bioequivalence. Secondary Objective: To evaluate the safety of Ailamod tablets (25 mg) supplied by Shenyang Xinrui Pharmaceutical Co., Ltd. and Ailamod tablets (25 mg, trade name: Aidesin®) certified by Hainan Xiansheng Pharmaceutical Co., Ltd. in a healthy adult population under fasting and postprandial administration conditions.

Start Date03 Nov 2025

Sponsor / Collaborator

Shenyang Xinrui Pharmaceutical Co., Ltd.

CTR20252595

/ CompletedNot Applicable

盐酸曲唑酮缓释片在健康受试者中单中心、随机、开放、单剂量、双周期、双交叉空腹和餐后状态下的生物等效性试验

[Translation] A single-center, randomized, open-label, single-dose, two-period, double-crossover bioequivalence study of trazodone hydrochloride extended-release tablets in healthy subjects under fasting and fed conditions

主要目的比较空腹和餐后给药条件下，沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片（150mg）与Az.Chim.Riun.Angelini Francesco Acraf S.P.A.持证的盐酸曲唑酮缓释片（150mg，商品名：曲特恪®TRITTICO®）在健康成年人群中吸收程度和速度的差异，评价其生物等效性。次要目的评价空腹和餐后给药条件下，沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片（150mg）与Az.Chim.Riun.Angelini Francesco Acraf S.P.A.持证的盐酸曲唑酮缓释片（150mg，商品名：曲特恪®TRITTICO®）的安全性。

[Translation]

Main purpose To compare the differences in the extent and rate of absorption of trazodone hydrochloride sustained-release tablets (150 mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and trazodone hydrochloride sustained-release tablets (150 mg, trade name: TRITTICO®) certified by Az.Chim.Riun.Angelini Francesco Acraf S.P.A. in healthy adults under fasting and postprandial administration conditions, and to evaluate their bioequivalence. Secondary purpose To evaluate the safety of trazodone hydrochloride sustained-release tablets (150 mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and trazodone hydrochloride sustained-release tablets (150 mg, trade name: TRITTICO®) certified by Az.Chim.Riun.Angelini Francesco Acraf S.P.A. under fasting and postprandial administration conditions.

Start Date02 Jul 2025

Sponsor / Collaborator

Shenyang Xinrui Pharmaceutical Co., Ltd.

CTR20243282

/ TerminatedNot Applicable

盐酸曲唑酮缓释片在健康受试者中单中心、开放、随机、单剂量、双周期、双交叉空腹和餐后状态下的生物等效性试验

[Translation] A single-center, open-label, randomized, single-dose, two-period, double-crossover bioequivalence study of trazodone hydrochloride extended-release tablets in healthy subjects under fasting and fed conditions

主要目的：比较空腹和餐后给药条件下，沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片（150mg）与Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A持证的盐酸曲唑酮缓释片（150mg，商品名：TRITTICO）在健康成年人群中吸收程度和速度的差异，评价其生物等效性。主要目的：评价空腹和餐后给药条件下，沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片（150mg）与Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A持证的盐酸曲唑酮缓释片（150mg，商品名：TRITTICO）在健康成年人群中的安全性。

[Translation]

Main purpose: To compare the trazodone hydrochloride sustained-release tablets (150mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and the licensed trazodone hydrochloride sustained-release tablets (Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A.) under fasting and postprandial administration conditions. 150 mg, trade name: TRITTICO) in healthy adults, to evaluate its bioequivalence. Main purpose: To evaluate the efficacy of trazodone hydrochloride sustained-release tablets (150 mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A's licensed trazodone hydrochloride sustained-release tablets ( 150 mg, trade name: TRITTICO) in healthy adults.

Start Date19 Aug 2024

Sponsor / Collaborator

Shenyang Xinrui Pharmaceutical Co., Ltd.

100 Clinical Results associated with Shenyang Xinrui Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenyang Xinrui Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Shenyang Xinrui Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenyang Xinrui Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Application

1

Login to view more data